Showing 261-280 of 503 for: Cochrane Systematic Reviews > Neurologic
- Light therapy for non-seasonal depression
Cochrane Systematic Reviews, 25-Mar-2009
Efficacy of light therapy for non-seasonal depression has been studied without any consensus on its efficacy.
- Lisuride for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 13-Nov-2008
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease
Cochrane Systematic Reviews, 13-Nov-2008
Long-term levodopa therapy in Parkinson's disease is associated with the development of motor complications including abnormal involuntary movements and a shortening response to each dose (wearing off phenomenon). It is thought that dopamine agonists can
- Local anaesthetic sympathetic blockade for complex regional pain syndrome
Cochrane Systematic Reviews, 28-Jul-2016
This review is an update of a previously published review in the Cochrane Database of Systematic Reviews, 2005, Issue 4 (and last updated in the Cochrane Database of Systematic Reviews, 2013 issue 8), on local anaesthetic blockade (LASB) of the sympatheti
- Local corticosteroid injection for carpal tunnel syndrome
Cochrane Systematic Reviews, 20-Oct-2008
Carpal tunnel syndrome is a clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the carpal tunnel in the wrist. Local corticosteroid injection for carpal tunnel syndrome has been studied but its effectiveness is unknown
- Losigamone add-on therapy for partial epilepsy
Cochrane Systematic Reviews, 9-Dec-2015
Epilepsy is a common neurologic disorder, affecting approximately 50 million people worldwide; nearly a third of these people are not well controlled by a single antiepileptic drug (AED) and usually require treatment with a combination of two or more AEDs
- Magnesium for acute traumatic brain injury
Cochrane Systematic Reviews, 14-Aug-2008
Acute traumatic brain injury is a leading cause of death and disability in young adults. Numerous pharmacological and non-pharmacological tools have been investigated and considered as potential mechanisms for improving neurological outcome. Magnesium has
- Magnesium sulphate and other anticonvulsants for women with pre-eclampsia
Cochrane Systematic Reviews, 29-Sep-2010
Eclampsia, the occurrence of a seizure (fit) in association with pre-eclampsia, is rare but potentially life-threatening. Magnesium sulphate is the drug of choice for treating eclampsia. This review assesses its use for preventing eclampsia.
- Magnesium sulphate for preventing preterm birth in threatened preterm labour
Cochrane Systematic Reviews, 8-Aug-2014
Magnesium sulphate has been used in some settings as a tocolytic agent to inhibit uterine activity in women in preterm labour with the aim of preventing preterm birth.
- Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
Cochrane Systematic Reviews, 22-Sep-2009
Epidemiological and basic science evidence suggests that magnesium sulphate before birth may be neuroprotective for the fetus.
- Magnesium sulphate versus lytic cocktail for eclampsia
Cochrane Systematic Reviews, 14-Mar-2011
Eclampsia, the occurrence of a seizure in association with pre-eclampsia, is a rare but serious complication of pregnancy. A number of different anticonvulsants have been used to control eclamptic fits and to prevent further seizures.
- Management of faecal incontinence and constipation in adults with central neurological diseases
Cochrane Systematic Reviews, 9-Jan-2014
People with central neurological disease or injury have a much higher risk of both faecal incontinence and constipation than the general population. There is often a fine line between the two symptoms, with any management intended to ameliorate one riskin
- Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings)
Cochrane Systematic Reviews, 5-Sep-2011
Cerebral toxoplasmosis or toxoplasmic meningoencephalitis (hereafter referred to as TE) was one of the first opportunistic infections to be described in human immunodeficiency virus (HIV) -infected patients. Treatment of TE has been relatively successful
- Mannitol and other osmotic diuretics as adjuncts for treating cerebral malaria
Cochrane Systematic Reviews, 15-Mar-2011
Cerebral oedema occurs with cerebral malaria, and some clinicians think osmotic diuretics, such as mannitol or urea, may improve outcomes.
- Mannitol for acute traumatic brain injury
Cochrane Systematic Reviews, 6-Aug-2013
Mannitol is sometimes effective in reversing acute brain swelling, but its effectiveness in the ongoing management of severe head injury remains unclear. There is evidence that, in prolonged dosage, mannitol may pass from the blood into the brain, where i
- Massage and touch for dementia
Cochrane Systematic Reviews, 26-May-2008
Massage and touch have been suggested as a non-pharmacological alternative or supplement to other treatments offered in order to reduce or manage a range of conditions associated with dementia such as anxiety, agitated behaviour and depression. It has als
- Mechanical insufflation-exsufflation for people with neuromuscular disorders
Cochrane Systematic Reviews, 22-Dec-2013
People with neuromuscular disorders (NMDs) may have weak respiratory (breathing) muscles which makes it difficult for them to effectively cough and clear mucus from the lungs. This places them at risk of recurrent chest infections and chronic lung disease
- Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease
Cochrane Systematic Reviews, 18-Feb-2013
Amyotrophic lateral sclerosis, also known as motor neuron disease, is a fatal neurodegenerative disease. Neuromuscular respiratory failure is the commonest cause of death, usually within two to five years of the disease onset. Supporting respiratory funct
- Medical and surgical treatment for ocular myasthenia
Cochrane Systematic Reviews, 1-Nov-2012
Approximately 50% of people with myasthenia gravis present with purely ocular symptoms, so called ocular myasthenia. Of these between 50% to 60% develop generalized disease, most within two years. Their management is controversial. This is an update of a
- Melatonin as add-on treatment for epilepsy
Cochrane Systematic Reviews, 17-Mar-2016
This is an updated version of the original Cochrane review published in Issue 6, 2012.